Comparison of Estramustine Phosphate, Methotrexate and cis-Platinum: in Patients with Advanced1 Hormone Refractory Prostate Cancer (Q70258003)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6343629%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

title

Comparison of estramustine phosphate, methotrexate and cis-platinum in patients with advanced, hormone refractory prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6343629%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

Comparison of Estramustine Phosphate, Methotrexate and cis-Platinum: in Patients with Advanced1 Hormone Refractory Prostate Cancer (English)

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)52509-4

3 October 2023

1 reference

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)52509-4

3 October 2023

author name string

S. A. Loening

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6343629

3 October 2023

S. Beckley

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6343629

3 October 2023

M. F. Brady

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6343629

3 October 2023

T. M. Chu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6343629

3 October 2023

J. B. deKernion

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6343629

3 October 2023

C. Dhabuwala

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6343629

3 October 2023

J. F. Gaeta

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6343629

3 October 2023

R. P. Gibbons

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6343629

3 October 2023

C. F. McKiel

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6343629

3 October 2023

D. G. McLeod

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6343629

3 October 2023

J. E. Pontes

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6343629

3 October 2023

G. R. Prout

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6343629

3 October 2023

P. T. Scardino

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6343629

3 October 2023

J. U. Schlegel

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6343629

3 October 2023

J. D. Schmidt

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6343629

3 October 2023

W. W. Scott

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6343629

3 October 2023

N. H. Slack

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6343629

3 October 2023

M. S. Soloway

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6343629

3 October 2023

G. P. Murphy

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6343629

3 October 2023

language of work or name

English

0 references

publication date

1 May 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6343629%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

9 October 2019

https://api.elsevier.com/content/article/PII:S0022534717525094?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)52509-4

https://api.elsevier.com/content/article/PII:S0022534717525094?httpAccept=text/plain

3 October 2023

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)52509-4

http://www.jurology.com/doi/pdf/10.1016/S0022-5347%2817%2952509-4

3 October 2023

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)52509-4

3 October 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6343629%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

volume

129

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6343629%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6343629%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

page(s)

1001-1006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6343629%20AND%20SRC:MED&resulttype=core&format=json

The continued evaluation of the effects of chemotherapy in patients with advanced carcinoma of the prostate

9 October 2019

cites work

2

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)52509-4

A Comparison of Estramustine Phosphate and Streptozotocin in Patients with Advanced Prostatic Carcinoma Who Have Had Extensive Irradiation

3 October 2023

3

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)52509-4

Comparison of Procarbazine, Imidazole-Carboxamide and Cyclophosphamide in Relapsing Patients with Advanced Carcinoma of the Prostate

3 October 2023

4

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)52509-4

The Use of Estramustine and Prednimustine Versus Prednimustine Alone in Advanced Metastatic Prostatic Cancer Patients Who Have Received Prior Irradiation

3 October 2023

5

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)52509-4

A comparison of hydroxyurea, methyl-chloroethyl-cyclohexy-nitrosourea and cyclophosphamide in patients with advanced carcinoma of the prostate

3 October 2023

6

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)52509-4

Comparison of Estramustine Phosphate and Vincristine Alone or in Combination for Patients with Advanced, Hormone Refractory, Previously Irradiated Carcinoma of the Prostate

3 October 2023

7

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)52509-4

Phase I study of high doses of methotrexate with citrovorum factor in patients with lung cancer

3 October 2023

9

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)52509-4

Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma

3 October 2023

11

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)52509-4

Pontine glioma. High-dose methotrexate and leucovorin rescue.

3 October 2023

13

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)52509-4

Methotrexate: an active drug in bladder cancer

3 October 2023

14

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)52509-4

Evaluation of chemotherapeutic responsiveness in Nb rat prostate cancer model. 5-fluorouracil, methotrexate, cyclophosphamide, and adriamycin

3 October 2023

15

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)52509-4

Treatment of advanced carcinoma of the prostate (stage D) with infusion of cis-diamminedichloroplatinum (II NSC 119875): a pilot study

3 October 2023

16

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)52509-4

Response criteria for the prostate of the USA national prostatic cancer project

3 October 2023

17

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)52509-4

Enzyme markers in human prostatic carcinoma

3 October 2023

18

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)52509-4

Clinical Significance of Serum Alkaline Phosphatase Isoenzyme Levels in Advanced Prostatic Carcinoma

3 October 2023

19

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)52509-4

Maximum utilization of the life table method in analyzing survival

3 October 2023

20

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)52509-4

Asymptotically Efficient Rank Invariant Test Procedures

3 October 2023

22

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)52509-4

Animal models of the hormone-sensitive and -insensitive prostatic adenocarcinomas, Dunning R-3327-H, R-3327-HI, and R-3327-AT

3 October 2023

24

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)52509-4

The importance of the stable category for chemotherapy treated patients with advanced and relapsing prostate cancer

3 October 2023

25

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)52509-4

3 October 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6343629%20AND%20SRC:MED&resulttype=core&format=json

9 October 2019

1 reference